In the realm of botulinum toxin type A, XEOMIN® shares similarities with BOTOX® COSMETIC. However, it distinguishes itself as a “naked injectable,” denoting a purer form of the toxin without the protein additives typically found in Botox. This purification process holds the promise of reducing the risk of treatment resistance. Having received FDA approval in 2010, XEOMIN® has swiftly emerged as a favored option for cosmetic and medical applications alike, offering a temporary relaxation of the wrinkle-causing muscles and resulting in a smooth and youthful complexion.